Stock Earnings TCRX stock rated a Buy by BTIG Research Tscan Therapeutics Inc’s recent filing unveils that its 10% Owner Lynx1 Capital Management LP acquired Company’s shares for reported $1.67
Stock Earnings Tscan Therapeutics Inc [TCRX] Shares Fall Approximately -85.30% Over the Year The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Stock Earnings Understanding the Risks of Investing in Tscan Therapeutics Inc (TCRX) Tscan Therapeutics Inc’s recent filing unveils that its 10% Owner Lynx1 Capital Management LP acquired Company’s shares for reported $0.29